ArticleJACC. Case reports2026
Decellularized Pulmonary Homograft Repair of Idiopathic Main Pulmonary Artery Aneurysm in SC Hemoglobinopathy.
Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPulmonary artery aneurysm is a rare and potentially fatal condition, often diagnosed incidentally. The lack of specific guidelines makes it difficult to define clear intervention criteria and the ideal reconstructive technique. Decellularized pulmonary homografts (DPHs) have emerged as a promising alternative, although they are still scarcely reported. CASE SUMMARY: A 48-year-old previously healthy man presented with mediastinal widening on a routine chest x-ray. Work-up revealed an idiopathic main pulmonary aneurysm measuring 52 mm, associated with moderate pulmonary valve stenosis. He underwent aneurysm resection and valve replacement with a DPH (size 25). The immediate postoperative course was satisfactory, but he developed severe pneumonia and was incidentally diagnosed with SC hemoglobinopathy. DISCUSSION: The use of a DPH was appropriate in this setting, particularly considering the patient's age and the presence of SC hemoglobinopathy, a condition associated with increased risk of pulmonary hypertension, thrombotic events, and vascular inflammation. Follow-up demonstrated a competent graft with no thromboembolic complications, reinforcing the potential benefit of this technique. TAKE-HOME MESSAGE: This case highlights the use of a DPH as a safe and effective surgical option for an idiopathic main pulmonary artery aneurysm, especially in patients with associated hematologic conditions, emphasizing the importance of strict follow-up and individualized therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.